Sign up
Quantellect · Congress · Trade Detail
NYSE: NVONovo Nordisk A/S
RepublicanHouse

Byron Donalds bought Novo Nordisk A/S (NYSE: NVO)

Byron Donalds (R-FL), a U.S. Representative, has disclosed 4 trades in Novo Nordisk A/S (NVO) since 2022, 2 purchases and 2 sales, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Byron Donalds bought $1,001 - $15,000 of Novo Nordisk A/S (NYSE: NVO) on October 7, 2022. Since that trade, NVO is up +8.20% against the S&P 500 up +114.24%, an outperformance of -106.04%.

Across these filings, Byron Donalds has been a balanced trader of NVO (a buy-to-sell ratio of 1.00). The most recent disclosed NVO transaction shown was dated March 20, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

NVO trades
4
Disclosed Vol
$32K
Buys
2
50%
Sells
2
50%
Buy / Sell
1.00
ratio
First → Last
2022–2025

Byron Donalds's NVO trades vs the price

NVO is up +8.20% since Byron Donalds bought on October 7, 2022, versus +114.24% for the S&P 500.

Performance since this trade

Price change since trade
+8.20%
S&P 500 change since trade
+114.24%
Outperformance vs S&P 500
-106.04%

All Byron Donalds NVO trades

TradedTypeSizeReturnEst. profit
March 20, 2025SELL$73.96-30.22%
March 20, 2025SELL$73.96-30.22%
October 7, 2022BUY$47.70+8.20%-$4K
October 7, 2022BUY$47.70+8.20%-$4K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Byron Donalds & NVO trading FAQ

Is it legal for Byron Donalds to trade Novo Nordisk A/S (NVO) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Novo Nordisk A/S (NVO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Byron Donalds buy NVO?

Byron Donalds disclosed a purchase of $1,001 - $15,000 of Novo Nordisk A/S (NVO) on October 7, 2022, according to public STOCK Act filings.

How has NVO performed since Byron Donalds's trade?

Since Byron Donalds bought NVO on October 7, 2022, the stock is up +8.20%, versus +114.24% for the S&P 500 over the same period, an outperformance of -106.04%.

How many times has Byron Donalds traded NVO?

Byron Donalds has disclosed 4 NVO trades since 2022 (2 purchases and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional NVO trades?

Quantellect tracks every disclosed congressional trade in Novo Nordisk A/S (NVO) on the Novo Nordisk A/S congressional trading page, which aggregates filings across all members of Congress.

Byron Donalds's NVO tradesAll congressional filings for Novo Nordisk A/SByron Donalds's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.